401 related articles for article (PubMed ID: 25163646)
1. Differences among brain tumor stem cell types and fetal neural stem cells in focal regions of histone modifications and DNA methylation, broad regions of modifications, and bivalent promoters.
Yoo S; Bieda MC
BMC Genomics; 2014 Aug; 15(1):724. PubMed ID: 25163646
[TBL] [Abstract][Full Text] [Related]
2. Global analysis of H3K4me3 and H3K27me3 profiles in glioblastoma stem cells and identification of SLC17A7 as a bivalent tumor suppressor gene.
Lin B; Lee H; Yoon JG; Madan A; Wayner E; Tonning S; Hothi P; Schroeder B; Ulasov I; Foltz G; Hood L; Cobbs C
Oncotarget; 2015 Mar; 6(7):5369-81. PubMed ID: 25749033
[TBL] [Abstract][Full Text] [Related]
3. An annotated list of bivalent chromatin regions in human ES cells: a new tool for cancer epigenetic research.
Court F; Arnaud P
Oncotarget; 2017 Jan; 8(3):4110-4124. PubMed ID: 27926531
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
Kar S; Patra SK
Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer.
Sasidharan Nair V; Toor SM; Taha RZ; Shaath H; Elkord E
Clin Epigenetics; 2018 Aug; 10(1):104. PubMed ID: 30081950
[TBL] [Abstract][Full Text] [Related]
6. Analysis of H3K4me3 and H3K27me3 bivalent promotors in HER2+ breast cancer cell lines reveals variations depending on estrogen receptor status and significantly correlates with gene expression.
Kaukonen D; Kaukonen R; Polit L; Hennessy BT; Lund R; Madden SF
BMC Med Genomics; 2020 Jul; 13(1):92. PubMed ID: 32620123
[TBL] [Abstract][Full Text] [Related]
7. Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial Diagnosis.
Curry E; Zeller C; Masrour N; Patten DK; Gallon J; Wilhelm-Benartzi CS; Ghaem-Maghami S; Bowtell DD; Brown R
Cancer Res; 2018 Mar; 78(6):1383-1391. PubMed ID: 29339543
[TBL] [Abstract][Full Text] [Related]
8. Bivalent promoter hypermethylation in cancer is linked to the H327me3/H3K4me3 ratio in embryonic stem cells.
Dunican DS; Mjoseng HK; Duthie L; Flyamer IM; Bickmore WA; Meehan RR
BMC Biol; 2020 Mar; 18(1):25. PubMed ID: 32131813
[TBL] [Abstract][Full Text] [Related]
9. An epigenetic signature of developmental potential in neural stem cells and early neurons.
Burney MJ; Johnston C; Wong KY; Teng SW; Beglopoulos V; Stanton LW; Williams BP; Bithell A; Buckley NJ
Stem Cells; 2013 Sep; 31(9):1868-80. PubMed ID: 23712654
[TBL] [Abstract][Full Text] [Related]
10. Chromatin remodeling and bivalent histone modifications in embryonic stem cells.
Harikumar A; Meshorer E
EMBO Rep; 2015 Dec; 16(12):1609-19. PubMed ID: 26553936
[TBL] [Abstract][Full Text] [Related]
11. Reprogramming cancer cells to pluripotency: an experimental tool for exploring cancer epigenetics.
Stricker S; Pollard S
Epigenetics; 2014 Jun; 9(6):798-802. PubMed ID: 24686321
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic modulation of metabolism in glioblastoma.
Dong Z; Cui H
Semin Cancer Biol; 2019 Aug; 57():45-51. PubMed ID: 30205139
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic analyses of planarian stem cells demonstrate conservation of bivalent histone modifications in animal stem cells.
Dattani A; Kao D; Mihaylova Y; Abnave P; Hughes S; Lai A; Sahu S; Aboobaker AA
Genome Res; 2018 Oct; 28(10):1543-1554. PubMed ID: 30143598
[TBL] [Abstract][Full Text] [Related]
14. Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells.
Chapman-Rothe N; Curry E; Zeller C; Liber D; Stronach E; Gabra H; Ghaem-Maghami S; Brown R
Oncogene; 2013 Sep; 32(38):4586-92. PubMed ID: 23128397
[TBL] [Abstract][Full Text] [Related]
15. Loss of the polycomb mark from bivalent promoters leads to activation of cancer-promoting genes in colorectal tumors.
Hahn MA; Li AX; Wu X; Yang R; Drew DA; Rosenberg DW; Pfeifer GP
Cancer Res; 2014 Jul; 74(13):3617-3629. PubMed ID: 24786786
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.
Yang Q; Tian Y; Ostler KR; Chlenski A; Guerrero LJ; Salwen HR; Godley LA; Cohn SL
BMC Cancer; 2010 Jun; 10():286. PubMed ID: 20546602
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic signatures and temporal expression of lineage-specific genes in hESCs during differentiation to hepatocytes in vitro.
Kim H; Jang MJ; Kang MJ; Han YM
Hum Mol Genet; 2011 Feb; 20(3):401-12. PubMed ID: 21059703
[TBL] [Abstract][Full Text] [Related]
18. Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells.
Ke XS; Qu Y; Cheng Y; Li WC; Rotter V; Øyan AM; Kalland KH
BMC Genomics; 2010 Nov; 11():669. PubMed ID: 21108828
[TBL] [Abstract][Full Text] [Related]
19. N
Xie Q; Wu TP; Gimple RC; Li Z; Prager BC; Wu Q; Yu Y; Wang P; Wang Y; Gorkin DU; Zhang C; Dowiak AV; Lin K; Zeng C; Sui Y; Kim LJY; Miller TE; Jiang L; Lee-Poturalski C; Huang Z; Fang X; Zhai K; Mack SC; Sander M; Bao S; Kerstetter-Fogle AE; Sloan AE; Xiao AZ; Rich JN
Cell; 2018 Nov; 175(5):1228-1243.e20. PubMed ID: 30392959
[TBL] [Abstract][Full Text] [Related]
20. Comparative analyses identify molecular signature of MRI-classified SVZ-associated glioblastoma.
Lin CA; Rhodes CT; Lin C; Phillips JJ; Berger MS
Cell Cycle; 2017 Apr; 16(8):765-775. PubMed ID: 28278055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
